Incyte (INCY) Revenue (2010 - 2026)

Incyte (INCY) reported Revenue of $1.3 billion for Q1 2026, up 20.87% on a YoY basis from $1.1 billion in Q1 2025, and down 15.54% quarter-over-quarter from $1.5 billion in Q4 2025.

Incyte (INCY) Revenue (2010 - 2026) Analysis & Trends

Incyte has reported Revenue for 17 years, with the latest figure at $1.3 billion in Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 20.87% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $5.4 billion (up 21.48% YoY), and the FY2025 full-year result was $5.1 billion, up 21.22% from the prior year.
  • Revenue for Q1 2026 stood at $1.3 billion, down from $1.5 billion in the prior quarter.
  • The five-year high for Revenue was $1.5 billion in Q4 2025, with the low at $733.2 million in Q1 2022.
  • Historically, Revenue has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
  • The largest YoY upside for Revenue was 29.15% in 2022 against a maximum downside of 1.27% in 2022.
  • Incyte's Revenue stood at $926.7 million in 2022, then grew by 9.35% to $1.0 billion in 2023, then climbed by 16.32% to $1.2 billion in 2024, then grew by 27.84% to $1.5 billion in 2025, then decreased by 15.54% to $1.3 billion in 2026.
  • The last three Revenue figures came in at $1.3 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 1.27 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.27 Bn
Dec 31, 2025 1.51 Bn
Sep 30, 2025 1.37 Bn
Jun 30, 2025 1.22 Bn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 1.18 Bn
Sep 30, 2024 1.14 Bn
Jun 30, 2024 1.04 Bn
Mar 31, 2024 880.89 Mn
Dec 31, 2023 1.01 Bn
Sep 30, 2023 919.03 Mn
Jun 30, 2023 954.61 Mn
Mar 31, 2023 808.67 Mn
Dec 31, 2022 926.70 Mn
Sep 30, 2022 823.30 Mn
Jun 30, 2022 911.40 Mn
Mar 31, 2022 733.24 Mn
Dec 31, 2021 862.85 Mn
Sep 30, 2021 812.99 Mn
Jun 30, 2021 705.71 Mn